Helping You Build Wealth With Honest Research
Since 1996. Read On...

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ZIM LABORATORIES Gains 8%; BSE HEALTHCARE Index Up 0.4%
Thu, 27 Jun 11:4

ZIM LABORATORIES Gains 8%; BSE HEALTHCARE Index Up 0.4%Image source: Nikada/www.istockphoto.com

ZIM LABORATORIES share price has zoomed 8% and is presently trading at Rs 113.4.

Meanwhile, the BSE HEALTHCARE index is at 36,826.7 (up 0.4%).

Among the top gainers in the BSE HEALTHCARE index today are SUVEN PHARMACEUTICALS (up 5.2%) and MAX HEALTHCARE INSTITUTE (up 5.1%).

KIMS (down 1.9%) and POLY MEDICURE (down 1.7%) are among the top losers today.

Over the last one year, ZIM LABORATORIES has moved up from Rs 112.1 to Rs 113.4, registering a gain of Rs 1.3 (up 1.2%).

On the other hand, the BSE HEALTHCARE index has moved up from 25,266.1 to 36,826.7, registering a gain of 45.8% during the last 12 months.

The top gainers among the BSE HEALTHCARE index stocks during this same period were Cadila Healthcare (up 90.1%), Glenmark Pharma (up 90.0%) and GSK Pharma (up 83.8%).

Must See: These Segments are Witnessing Incredible Growth with Modi's Push

What About the Benchmark Indices?

The BSE Sensex is at 78,739.7 (up 0.1%).

The top gainers among the BSE Sensex today are Ultratech Cement (up 3.2%) and JSW Steel (up 1.6%). The most traded stocks in the BSE Sensex are Tata Steel and M&M.

In the meantime, NSE Nifty is at 23,889.3 (up 0.1%). Ultratech Cement and Grasim Industries are among the top gainers in NSE NIFTY.

Over the last 12 months, the BSE Sensex has moved up from 62,970.0 to 78,739.7, registering a gain of 15,769.7 points (up 25.0%).

ZIM LABORATORIES Financial Update...

ZIM LABORATORIES net profit grew 11.7% YoY to Rs 81 million for the quarter ended March 2024, compared to a profit of Rs 72 million a year ago. Net sales rose 11.8% to Rs 1,179 million during the period as against Rs 1,054 million in January-March 2023.

For the year ended March 2024, ZIM LABORATORIES reported 29.4% decrease in net profit to Rs 172 million compared to net profit of Rs 244 million during FY23. Revenue of the company fell 7.8% to Rs 3,674 million during FY24.

The current Price to earnings ratio of ZIM LABORATORIES, based on rolling 12 month earnings, stands at 32.0.


Equitymaster requests your view! Post a comment on "ZIM LABORATORIES Gains 8%; BSE HEALTHCARE Index Up 0.4%". Click here!